Next Article in Journal
A 50-Year-Old Patient with Guillain–Barré Syndrome after COVID-19: A Case Report
Previous Article in Journal
A Comparison of Diagnosed Skin Diseases between the Years with and without COVID-19 Pandemic
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Medicina
Volume 57
Issue 8
10.3390/medicina57080774
medicina-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Vitamin D Deficiency as a Risk Factor for Myocardial Ischemia

by
Christina Batsi
1,
Evangelia Gkika
1,
Loukas Astrakas
2,
Athanassios Papadopoulos
2,
Ioannis Iakovou
3,
Alexandros Dogoritis
4,
Andreas Fotopoulos
1 and
Chrissa Sioka
1,4,*
1
Department of Nuclear Medicine, University Hospital of Ioannina, 45500 Ioannina, Greece
2
Department of Medical Physics, University Hospital of Ioannina, 45500 Ioannina, Greece
3
2nd Nuclear Medicine Laboratory, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece
4
Neurosurgical Institute of Ioannina, University of Ioannina, 45500 Ioannina, Greece
*
Author to whom correspondence should be addressed.
Medicina 2021, 57(8), 774; https://doi.org/10.3390/medicina57080774
Submission received: 26 June 2021 / Revised: 21 July 2021 / Accepted: 27 July 2021 / Published: 29 July 2021
(This article belongs to the Section Cardiology)
Browse Figures
Review Reports Versions Notes

Abstract

:
Background and Objectives: Vitamin D (Vit D) deficiency has been implicated in various conditions, including cardiovascular disease. The purpose of this retrospective study was to investigate the incidence of patients with myocardial ischemia in relation to their serum levels of vitamin D. Materials and Methods: A 64-month search (January 2016 to April 2021) in our database of the Nuclear Medicine Laboratory revealed 113 patients who had both myocardial perfusion imaging with single photon emission computed tomography (MPI SPECT) and Vit D measurements. MPI SPECT obtained myocardial images during both stress (summed stress score, SSS) and rest (summed rest score, SRS). Abnormal MPI SPECT was when the SSS was ≥4. Vit D was determined by radioimmunoassay (RIA). Patients with Vit D values <10 ng/mL, 10–29 ng/mL and ≥30 ng/mL were defined as having a deficiency, insufficiency and sufficiency, respectively. Results: Among patients, 46/113 (40.7%) were male and 67/113 (59.3%) were female. Abnormal MPI was found in 58/113 (51.3%) patients. Vit D deficiency was noted in 20/113 (17.7%) patients, insufficiency in 86/113 (76.1%) patients, and normal Vit D was noted in only 7/113 (6.2%) patients. Sixteen of the 20 patients (80%) with Vit D deficiency, and 38/86 (44.2%) with insufficiency had an abnormal MPI SPECT. In contrast, only 1/7 (14.3%) patients with sufficient Vit D levels had an abnormal MPI SPECT. The Mann-Whitney U-test showed that ischemia reduced the values of Vit D. Correlation analysis showed a negative association of Vit D levels with SSS (rho = −0.232, p = 0.014) and SRS (rho = −0.250, p = 0.008). Further evaluation with a Vit D cut off 20 ng/mL retrieved no statistical significance. Finally, Vit D and gender were independently associated with myocardial ischemia. Conclusions: Low Vit D levels may represent a risk factor for myocardial ischemia.

1. Introduction

A variety of cardiac biomarkers exist that may be used to diagnose acute coronary syndromes. These biomarkers include creatine kinase myocardial-specific isoenzyme (CK-MB), myoglobin, troponin I and brain natriuretic peptide (BNP) [1]. Utilizing these biomarkers, acute myocardial infarction may be diagnosed safely only 6 h after the event [2]. In addition, serum troponin levels may be useful to assess the risk of sudden cardiac death. [3].
Vitamin D (Vit D) deficiency is present in up to 50% of the general population [4]. Several studies have investigated the implications of low Vit D in several conditions, such as multiple sclerosis (MS), where Vit D consist of a marker for bone loss [5,6]. Low bone mineral density (BMD) may be affected by several parameters in healthy individuals, as well as in patients with various diseases [7,8,9,10,11,12,13,14]. Furthermore, the role of low BMD in patients with coronary artery disease has been well studied, where a correlation was described between low BMD and the number of constricted coronary arteries, indicating that low BMD may represent an independent risk factor for CAD [15,16,17,18]. Thus, low BMD and CAD seem to correlate and share a common implicating marker, and that’s Vit D [5,19].
The etiology of these associations between Vit D and various conditions stems from the fact that Vit D has an impact on multiple biologic pathways important to autoimmunity, cancer, cardiovascular disease, infectious disease, and other conditions [19].
Low Vit D levels may result in vascular inflammation, coronary arterial dysfunction and postinfarction complications [20], as well as adverse cardiovascular outcomes [4]. Apart from the traditional cardiovascular risk factors, Vit D deficiency may predict worse coronary artery disease, and even an increased number of affected coronary arteries [21]. Vit D deficiency may even be the etiology of myocardial dysfunction in patients with silent ischemia and no known history of coronary artery disease [22].
According to the European Society of Cardiology (ESC) new published guidelines in symptomatic patients, a non-invasive procedure is considered a proper initial investigation [23]. Myocardial perfusion imaging (MPI) with single photon emission computed tomography (SPECT), is a noninvasive functional imaging method used in several diseases for myocardial evaluation [24,25,26]. MPI can image myocardial ischemia in patients even in the absence of specific cardiac symptomatology [27,28,29]. The diagnostic accuracy of MPI SPECT compared with conventional coronary angiography is similar for both men and women, with a mean sensitivity and specificity of 84.2% and 78.7% for SPECT MPI in women, and 89.1% and 71.2% for MPI SPECT in men, respectively [30].
The aim of the present study was to evaluate whether the variations in the Vit D levels are linked to myocardial ischemia.

2. Materials and Methods

2.1. Participants and Procedures

We retrospectively reviewed in the medical records of the Nuclear Medicine Department of our University Hospital, all the MPIs of patients between January 2016 and April 2021 (a total of 64 months), which also had a Vit D measurement within 6 months prior or post MPI. No exclusion criteria were used, concerning the etiology of the MPI exam, their medical history, or their cardiovascular status. Our search retrieved 113 MPIs of 67 female and 46 male Caucasian patients that also had Vit D measurement. Their mean age was 64.9 years, 63.7 years for males and 65.7 years for females.
The patients underwent stress/rest MPI SPECT according to previously published guidelines [31]. MPI evaluation and interpretation was performed independently by two experienced nuclear medicine physicians, blinded to the final diagnosis, and possible disagreements were solved by consensus. SPECT findings were based on a 17-segment model and scored separately for the stress (SSS) and rest (SRS) images, as described previously [32]. A summed difference score (SDS), calculated by subtracting the SRS from the SSS, consisted of a semiquantitative measure of the severity of the reversible ischemic myocardial perfusion defects. Aberrant MPI SPECT denoting ischemia was deemed to be when SSS was ≥4. Myocardial ischemia was considered as mild when SSS was 4 to 8, moderate 9 to 13, and serious with SSS > 13 [27].
Vit D was measured by radioimmunoassay (RIA) (DIAsource 25OH Vitamin D total -RIA-CT Kit), which is an accurate and validated method. The specimen collection, preparation and procedure were performed according to the manufacturer instructions (DIAsource ImmunoAssays S.A). Patients with Vit D values < 10 ng/mL, 10–29 ng/mL and ≥30 ng/mL were considered to have a deficiency, insufficiency and sufficiency, respectively.

2.2. Statistical Analysis

MPI scores were evaluated with Vit D cutoff values of 10 ng/mL, and further with cutoff values of 20 ng/ml. Seasonal Vit D was separated into two groups. The first group was patients who had Vit D from September to February and the second group from March to August.
Nonparametric statistics were used because the Kolmogorov–Smirnov test revealed the deviation of the variables from the normal distribution. The Spearman rho correlation coefficient was used to assess association of Vit D levels with the SSS, SRS and SDS scores and age. The Mann-Whitney U-test was used to compare Vit D levels between the subjects with and without ischemia, and between men and women. Patients with normal MPI and no ischemia, were considered as control group. Backward stepwise multivariate logistic regression was used to identify the independent predictors of ischemia among Vit D, gender, and age. A statistical analysis was performed using SPSS software (version 23.0, IBM). Two-tailed values of p < 0.05 were regarded as statistically significant.

2.3. Ethics

This retrospective study was performed after approval by the Hospital’s Clinical Research Committee. Our Hospital’s Clinical Research Committee does not require written patient’s consent in retrospective studies. All collected data were coded with no patient personal information provided, and the statistical analysis was performed blinded.

3. Results

Among 113 MPIs, 58/113 (51.3%) patients had normal, and 55/113 (48.7%) patients had abnormal MPI. Figure 1 and Figure 2 show images of the myocardial perfusion schintigraphy of a normal and abnormal MPI, respectively. Their Vit D scores indicated Vit D deficiency in 20/113 (17.7%) patients, insufficiency in 86/113 (76.1%) and sufficiency in 7/113 (6.2%) patients. Amongst the 20 patients with Vit D deficiency, 16 demonstrated abnormal MPI (80%), and between the 86 patients with Vit D insufficiency, 38 exhibited abnormal MPI (44.2%), in contrast to only 1 in 7 patients with normal Vit D values that had an abnormal MPI (14.3%).
Correlation analysis showed a negative association of Vit D levels with SSS (rho = −0.232, p = 0.014) and SRS (rho = −0.250, p = 0.008). No association was found between the Vit D levels and SDS (rho = −0.003, p = 0.975) or age (rho = −0.140, p = 0.139). The Mann-Whitney U test showed that ischemia lowers the values of Vit D, (Table 1, Figure 3). There was no difference in Vit D levels between men and women. When applying a Vit D cutoff value of 20 ng/mL, there were 63/113 (55.75%) and 50/113 (44.25%) patients with less than and over 20 ng/mL Vit D, respectively. Among them, there were 39/63 (61.9%) patients with abnormal and 16/50 (32%) patients with normal MPI. Statistical analysis found no significance with any of the studied parameters. Interestingly, the analysis showed that Vit D and gender were independent risk factors for myocardial ischemia, with male gender at more risk compared to females.

4. Discussion

Cardiovascular disease consists of an important escalating challenge in European countries, responsible for approximately 45% of all deaths. Some countries, such as Greece, demonstrate a current failure to effectively adjust the modifiable risk factors leading to deaths secondary to stroke or ischemic heart disease. [33]
Although several noninvasive imaging tests exist to assess the status of myocardial function and of coronary arteries [34], MPI is widely available and reliable test with high sensitivity [35]. In most cases, an abnormal MPI indicates myocardial ischemia due to coronary artery disease. However, several other non-cardiac conditions may coexist, such as depression, anxiety, or Vit D deficiency, which may affect myocardial function and lead to an abnormal MPI without coronary artery disease [27,28].
In our study, most patients had either Vit D deficiency (17.7%) or insufficiency (76.1%), and very few (6.2%) had normal values of Vit D. In several studies, Vit D deficiency or insufficiency have been frequently reported in various countries. Thus, Vit D inadequacy has been reported in 36% of young adults and 57% of hospitalized patients in the United States [36]. In central Europe, Vit D levels have been reported on an average below the 30 ng/mL level [37]. In Greece, the Mediterranean paradox exists, consisting of a higher Vit D deficiency compared to other European countries, even though a high exposure to sunlight exists throughout the year. This paradox is unclear, but it has been attributed to various reasons including the low nutritional Vit D intake of the Greek population [38].
Vit D deficiency may increase the risk of osteoporosis, cancer [39] and cardiovascular conditions [40,41]. However, a systematic review and meta-analysis based on 51 clinical trials of moderate quality, failed to demonstrate a significant reduction in mortality and cardiovascular risk associated with Vit D [42]. In our study, we found a significant association of Vit D and myocardial ischemia, because low Vit D was an independent predictor of myocardial ischemia. Another recent study reported that low Vit D levels were associated with an increased risk of coronary artery disease [43]. Similarly, Vit D status in a cohort of 478 patients with acute myocardial infarction showed significantly low levels of Vit D in 431 of the 478 individuals [44]. Likewise, a study concluded that low serum Vit D was an independent risk factor for acute myocardial infarction, especially in patients with Vit D levels < 20 ng/mL [45]. In our study, the statistical analysis revealed no significant impact of a Vit D cutoff value of 20 ng/mL on myocardial ischemia.
In our study, no association was found between gender and Vit D levels, but male gender was an independent risk factor for myocardial ischemia. In contrast, a previous study reported that female gender was associated with increased severity of coronary artery disease and independently associated with significant Vit D deficiency [46]. However, several studies have reported that such variations between men and women in some studies may be due to variations in the presentation of the coronary artery disease in women, frequently with atypical symptoms, or with asymptomatic myocardial ischemia, leading to a delayed diagnosis of ischemia until when it is already advanced [47]. Additionally, compared with men, symptomatic women with angina and proven myocardial ischemia frequently have no significant coronary artery stenosis on angiography, but rather coronary microvascular dysfunction [48].,
In respect to seasonal variation, it was found in a group of patients with acute myocardial infarction that Vit D deficiency was less prominent during the period from July to the end of September, and it could be predicted by autumn/winter sampling [44]. In our cases, no statistical significance was found between the seasonal Vit D and myocardial ischemia.
Limitations of our study include its retrospective nature, with consequences consisted of incomplete medical history of participants and their physical characteristics. In addition, no information was available concerning the patients’ recent status, as well as further serum/plasma markers such as CK, CK-MB, cardiac troponin T, troponin I and myoglobin. In any event, our study demonstrated that Vit D levels had a negative association with SSS and SRS, indices associated with myocardial dysfunction. Since MPI SPECT represents a consistently reliable non-invasive imaging method, it may be used in individuals with low Vit D to rule out myocardial involvement. Further, prospective controlled studies are needed to verify our findings.

5. Conclusions

Low levels of vitamin D were associated with higher SSS and SRS, which indicate myocardial dysfunction. However, no statistical significance was noticed between the seasonal vitamin D levels and myocardial ischemia. Even though no association was found between gender and vitamin D levels, myocardial ischemia was more common in men compared to women. Further prospective, controlled studies are needed to verify our findings.

Author Contributions

Methodology, C.B. and C.S.; formal analysis, A.P. and L.A.; investigation, A.D. and E.G.; writing—original draft preparation, C.B. and E.G.; writing—review and editing, C.S. and I.I.; supervision, C.S. and A.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of the University Hospital of Ioannina (protocol code: 34; date of approval: 11 February 2021).

Informed Consent Statement

Patient consent was waived because, in retrospective studies, our Hospital’s Clinical Research Committee does not require written patient consent. Additionally, all the collected data were coded with no patient personal information provided, and thus no patient could be identified.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy issues.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hung, C.L.; Chien, D.K.; Shih, S.C.; Chang, W.H. The feasibility and diagnostic accuracy by multiple cardiac biomarkers in emergency chest pain patients: A clinical analysis to compare 290 suspected acute coronary syndrome cases stratified by age and gender in Taiwan. BMC Cardiovasc. Disord. 2016, 16, 191. [Google Scholar] [CrossRef] [Green Version]
  2. Lim, W.Y.; Thevarajah, T.M.; Goh, B.T.; Khor, S.M. Paper microfluidic device for early diagnosis and prognosis of acute myocardial infarction via quantitative multiplex cardiac biomarker detection. Biosens. Bioelectron. 2019, 128, 176–185. [Google Scholar] [CrossRef] [PubMed]
  3. Carvajal-Zarrabal, O.; Hayward-Jones, P.M.; Nolasco-Hipolito, C.; Barradas-Dermitz, D.M.; Calderón-Garcidueñas, A.L.; López-Amador, N. Use of Cardiac Injury Markers in the Postmortem Diagnosis of Sudden Cardiac Death. J. Forensic Sci. 2017, 62, 1332–1335. [Google Scholar] [CrossRef] [PubMed]
  4. Lee, J.H.; O’Keefe, J.H.; Bell, D.; Hensrud, D.D.; Holick, M.F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J. Am. Coll. Cardiol. 2008, 52, 1949–1956. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Sioka, C.; Kyritsis, A.P.; Fotopoulos, A. Multiple sclerosis, osteoporosis, and vitamin D. J. Neurol. Sci. 2009, 287, 1–6. [Google Scholar] [CrossRef] [PubMed]
  6. Sioka, C.; Papakonstantinou, S.; Markoula, S.; Gkartziou, F.; Georgiou, A.; Georgiou, I.; Pelidou, S.H.; Kyritsis, A.P.; Fotopoulos, A. Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece. J. Negat. Results Biomed. 2011, 10, 3. [Google Scholar] [CrossRef] [Green Version]
  7. Sioka, C.; Fotopoulos, A.; Georgiou, A.; Xourgia, X.; Papadopoulos, A.; Kalef-Ezra, J.A. Age at menarche, age at menopause and duration of fertility as risk factors for osteoporosis. Climacteric 2010, 13, 63–71. [Google Scholar] [CrossRef]
  8. Sioka, C.; Bougias, C.; Papadopoulos, A.; Fotopoulos, A. Is osteoporosis in postmenopausal female patients related to previous pregnancies and/or miscarriages? Climacteric 2007, 10, 381–385. [Google Scholar] [CrossRef] [PubMed]
  9. Sioka, C.; Fotopoulos, A.; Papakonstantinou, S.; Georgiou, A.; Pelidou, S.H.; Kyritsis, A.P.; Kalef-Ezra, J.A. The effect of menarche age, parity and lactation on bone mineral density in premenopausal ambulatory multiple sclerosis patients. Mult. Scler. Relat. Disord. 2015, 4, 287–290. [Google Scholar] [CrossRef]
  10. Markoula, S.; Sioka, C.; Exarchopoulos, T.; Chatzistefanidis, D.; Kalef-Ezra, J.; Fotopoulos, A.; Kyritsis, A.P. Gender specific association of decreased bone mineral density in patients with epilepsy. Neurol. Neurochir. Pol. 2015, 49, 267–271. [Google Scholar] [CrossRef]
  11. Sioka, C.; Fotopoulos, A.; Georgiou, A.; Papakonstantinou, S.; Pelidou, S.H.; Kyritsis, A.P.; Kalef-Ezra, J.A. Body composition in ambulatory patients with multiple sclerosis. J. Clin. Densitom. 2011, 14, 465–470. [Google Scholar] [CrossRef]
  12. Sioka, C.; Papakonstantinou, S.; Fotopoulos, A.; Alamanos, Y.; Georgiou, A.; Tsouli, S.; Pelidou, S.H.; Kyritsis, A.P.; Kalef-Ezra, J. Bone mineral density in ambulatory patients with multiple sclerosis. Neurol. Sci. 2011, 32, 819–824. [Google Scholar] [CrossRef]
  13. Sioka, C.; Baldouma, A.; Papadopoulos, A.; Petrikis, P.; Batsi, C.; Kostadima, V.; Fotopoulos, A.; Kyritsis, A.P. Co-Existence of Depression, Low Bone Mineral Density, and Vitamin D Deficiency in Patients with Multiple Sclerosis. Psychiatr. Danub. 2021, 33, 201. [Google Scholar]
  14. Sioka, C.; Bougias, C.; Al-Bokharhli, J.; Fotopoulos, A. Smoking and alcohol use as risk factors for low bone mineral density. Rheumatol. Int. 2006, 27, 207–208. [Google Scholar] [CrossRef]
  15. Wang, Y.; Wang, R.; Liu, Y.; Bai, L.; Liu, L.; He, L.; Deng, H.; Li, T.; Xu, S.; Chen, L.; et al. Associations between bone mineral density in different measurement locations and coronary artery disease: A cross-sectional study. Arch. Osteoporos 2021, 16, 100. [Google Scholar]
  16. Park, J.; Yoon, Y.E.; Kim, K.M.; Hwang, I.C.; Lee, W.; Cho, G.Y. Prognostic value of lower bone mineral density in predicting adverse cardiovascular disease in Asian women. Heart 2021, 7, 1040–1046. [Google Scholar] [CrossRef] [PubMed]
  17. Sioka, C.; Goudevenos, J.; Pappas, K.; Bougias, C.; Papadopoulos, A.; Grammatikopoulos, K.; Fotopoulos, A. Bone mineral density and coronary atherosclerosis. Calcif. Tissue. Int. 2007, 81, 333. [Google Scholar] [CrossRef] [PubMed]
  18. Ahmadi, N.; Mao, S.S.; Hajsadeghi, F.; Arnold, B.; Kiramijyan, S.; Gao, Y.; Flores, F.; Azen, S.; Budoff, M. The relation of low levels of bone mineral density with coronary artery calcium and mortality. Osteoporos. Int. 2018, 29, 1609–1616. [Google Scholar] [CrossRef]
  19. Wacker, M.; Holick, M.F. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol 2013, 5, 51–108. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Mozos, I.; Marginean, O. Links between Vitamin D Deficiency and Cardiovascular Diseases. Biomed. Res. Int. 2015, 2015, 109275. [Google Scholar] [CrossRef]
  21. El Mokadem, M.; Boshra, H.; Abd El Hady, Y.; Abd El Hameed, A.S. Relationship of serum vitamin D deficiency with coronary artery disease severity using multislice CT coronary angiography. Clin. Investig. Arterioscler. 2021. [Google Scholar] [CrossRef]
  22. Ozer, P.K.; Emet, S.; Karaayvaz, E.B.; Elitok, A.; Bilge, A.K.; Adalet, K.; Oncul, A. Silent myocardial dysfunction in vitamin D deficiency. Arch. Med. Sci. Atheroscler. Dis. 2020, 5, e153–e162. [Google Scholar] [CrossRef] [PubMed]
  23. Saraste, A.; Knuuti, J. ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: Recommendations for cardiovascular imaging. Herz 2020, 45, 409–420. [Google Scholar] [CrossRef]
  24. Sioka, C.; Nikas, D.; Tsoumani, A.; Kiortsis, D.N.; Fotopoulos, A.; Kostadima, V. Transient myocardial ischemia due to corticosteroid use in a patient with multiple sclerosis diagnosed with myocardial perfusion imaging. J. Nucl. Cardiol. 2020. [Google Scholar] [CrossRef]
  25. Kotsalou, I.; Georgoulias, P.; Karydas, I.; Fourlis, S.; Sioka, C.; Zoumboulidis, A.; Demakopoulos, N. A rare case of myocardial infarction and ischemia in a cannabis-addicted patient. Clin. Nucl. Med. 2007, 32, 130–131. [Google Scholar] [CrossRef]
  26. Sioka, C.; Exarchopoulos, T.; Tasiou, I.; Tzima, E.; Fotou, N.; Capizzello, A.; Ragos, V.; Tsekeris, P.; Fotopoulos, A. Myocardial perfusion imaging with (99 m)Tc-tetrofosmin SPECT in breast cancer patients that received postoperative radiotherapy: A case-control study. Radiat. Oncol. 2011, 6, 151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Fotopoulos, A.; Petrikis, P.; Iakovou, I.; Papadopoulos, A.; Sakelariou, K.; Gkika, E.; Lakkas, L.; Touzios, C.; Pappas, K.; Klaroudas, A.; et al. The impact of depression and anxiety in prognosis of patients undergoing myocardial perfusion imaging with 99mTc tetrofosmin SPECT for evaluation of possible myocardial ischemia. Nucl. Med. Rev. Cent. East. Eur. 2020, 23, 58–62. [Google Scholar] [CrossRef]
  28. Sioka, C.; Papadimitropoulos, K.; Michalis, L.; Pappas, K.; Lakkas, L.; Fotopoulos, A.; Dounousi, E. Myocardial ischemia with normal coronary angiography in a chronic kidney disease patient. Cardiol. J. 2019, 26, 620–621. [Google Scholar] [CrossRef] [Green Version]
  29. Giannopoulos, S.; Markoula, S.; Sioka, C.; Zouroudi, S.; Spiliotopoulou, M.; Naka, K.K.; Michalis, L.K.; Fotopoulos, A.; Kyritsis, A.P. Detecting myocardial Ischemia With (99m)Technetium-Tetrofosmin Myocardial Perfusion Imaging in Ischemic Stroke. Neurohospitalist 2017, 7, 164–168. [Google Scholar] [CrossRef] [PubMed]
  30. Iskandar, A.; Limone, B.; Parker, M.W.; Perugini, A.; Kim, H.; Jones, C.; Calamari, B.; Coleman, C.I.; Heller, G.V. Gender differences in the diagnostic accuracy of SPECT myocardial perfusion imaging: A bivariate meta-analysis. J. Nucl. Cardiol. 2013, 20, 53–63. [Google Scholar] [CrossRef] [PubMed]
  31. Verberne, H.J.; Acampa, W.; Anagnostopoulos, C.; Ballinger, J.; Bengel, F.; De Bondt, P.; Buechel, R.R.; Cuocolo, A.; van Eck-Smit, B.L.; Flotats, A.; et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur. J. Nucl. Med. Mol. Imaging. 2015, 42, 1929–1940. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Fotopoulos, A.; Papadimitropoulos, K.; Papadopoulos, A.; Lakkas, L.; Spiliotopoulou, M.; Kotrotsios, T.D.; Pappas, K.; Notopoulos, A.; Sioka, C. Myocardial ischemia in female patients with rheumatoid arthritis assessed with single photon emission tomography-myocardial perfusion imaging. Nucl. Med. Rev. Cent. East. Eur. 2019, 22, 8–13. [Google Scholar] [PubMed]
  33. Michas, G.; Karvelas, G.; Trikas, A. Cardiovascular disease in Greece; the latest evidence on risk factors. Hellenic J. Cardiol. 2019, 60, 271–275. [Google Scholar] [CrossRef]
  34. Mangla, A.; Oliveros, E.; Williams, K.A., Sr.; Kalra, D.K. Cardiac Imaging in the Diagnosis of Coronary Artery Disease. Curr. Probl. Cardiol. 2017, 42, 316–366. [Google Scholar] [CrossRef]
  35. Jaarsma, C.; Leiner, T.; Bekkers, S.C.; Crijns, H.J.; Wildberger, J.E.; Nagel, E.; Nelemans, P.J.; Schalla, S. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: A meta-analysis. J. Am. Coll. Cardiol. 2012, 59, 1719–1728. [Google Scholar] [PubMed] [Green Version]
  36. Holick, M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo. Clin. Proc. 2006, 81, 353–373. [Google Scholar] [CrossRef] [Green Version]
  37. Płudowski, P.; Grant, W.B.; Bhattoa, H.P.; Bayer, M.; Povoroznyuk, V.; Rudenka, E.; Ramanau, H.; Varbiro, S.; Rudenka, A.; Karczmarewicz, E.; et al. Vitamin D Status in Central Europe. Int. J. Endocrinol. 2014, 589587. [Google Scholar] [CrossRef] [PubMed]
  38. Manios, Y.; Moschonis, G.; Hulshof, T.; Bourhis, A.S.; Hull, G.L.J.; Dowling, K.G.; Kiely, M.E.; Cashman, K.D. Prevalence of vitamin D deficiency and insufficiency among schoolchildren in Greece: The role of sex, degree of urbanisation and seasonality. Br. J. Nutr. 2017, 118, 550–558. [Google Scholar] [CrossRef] [Green Version]
  39. Hilger, J.; Friedel, A.; Herr, R.; Rausch, T.; Roos, F.; Wahl, D.A.; Pierroz, D.D.; Weber, P.; Hoffmann, K. A systematic review of vitamin D status in populations worldwide. Br. J. Nutr. 2014, 111, 23–45. [Google Scholar] [CrossRef] [Green Version]
  40. Pittas, A.G.; Chung, M.; Trikalinos, T.; Mitri, J.; Brendel, M.; Patel, K.; Lichtenstein, A.H.; Lau, J.; Balk, E.M. Systematic review: Vitamin D and cardiovascular outcomes. Ann. Intern. Med. 2010, 152, 307–314. [Google Scholar] [CrossRef]
  41. Kunadian, V.; Ford, G.A.; Bawamia, B.; Qiu, W.; Manson, J.E. Vitamin D deficiency and coronary artery disease: A review of the evidence. Am. Heart J. 2014, 167, 283–291. [Google Scholar] [CrossRef] [PubMed]
  42. Elamin, M.B.; Abu Elnour, N.O.; Elamin, K.B.; Fatourechi, M.M.; Alkatib, A.A.; Almandoz, J.P.; Liu, H.; Lane, M.A.; Mullan, R.J.; Hazem, A.; et al. Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2011, 96, 1931–1942. [Google Scholar] [CrossRef] [Green Version]
  43. Norouzi, H.; Ziaie, N.; Saravi, M.; Norouzi, A.; Noei-Teymoordash, S.; Jokar-Darzi, F.; Norouzi, F.; Rajabi-Fumashi, M.; Zahedi-Tajrishi, F.; Norouzi, S. Association of vitamin D deficiency and premature coronary artery disease. Caspian J. Intern. Med. 2019, 10, 80–85. [Google Scholar] [PubMed]
  44. Aleksova, A.; Belfiore, R.; Carriere, C.; Kassem, S.; La Carrubba, S.; Barbati, G.; Sinagra, G. Vitamin D Deficiency in Patients with Acute Myocardial Infarction: An Italian Single-Center Study. Int. J. Vitam. Nutr. Res. 2015, 85, 23–30. [Google Scholar] [CrossRef] [PubMed]
  45. Akter, K.; Khalilullah, I.; Saqueeb, S.N.; Islam, A.; Zaman, M.S.; Rahman, M.; Rokonujjaman, M.; Wadud, M.A.; Aziz, S.; Rahman, M.A.; et al. Level of Serum Vitamin D, To Which People Are at Risk of Developing Acute Myocardial Infarction in Bangladesh. Mymensingh Med. J. 2021, 30, 176–181. [Google Scholar]
  46. Verdoia, M.; Schaffer, A.; Barbieri, L.; Di Giovine, G.; Marino, P.; Suryapranata, H.; De Luca, G. Novara Atherosclerosis Study Group (NAS). Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease. Nutr. Metab. Cardiovasc. Dis. 2015, 25, 464–470. [Google Scholar] [CrossRef]
  47. Davies, R.E.; Rier, J.D. Gender Disparities in CAD: Women and Ischemic Heart Disease. Curr. Atheroscler. Rep. 2018, 20, 51. [Google Scholar] [CrossRef]
  48. Waheed, N.; Elias-Smale, S.; Malas, W.; Maas, A.H.; Sedlak, T.L.; Tremmel, J.; Mehta, P.K. Sex differences in non-obstructive coronary artery disease. Cardiovasc. Res. 2020, 116, 829–840. [Google Scholar] [CrossRef]
Medicina 57 00774 g001 550
Figure 1. Normal MPI (a summed stress score less than 4). This image shows a normal MPI. The arrow points to a nonsignificant finding seen in the apical portion of the anterior wall of the left ventricle. The visual SSS was 1 (SSS < 4). (A) The three axis images show stress and rest MPI images in the short axis (i), vertical axis (ii) and horizontal axis (iii). (B) The bull’s eye image shows the entire myocardium. The red arrow shows the finding seen in the stress MPI, and the white arrow shows the improvement of the finding at rest.
Figure 1. Normal MPI (a summed stress score less than 4). This image shows a normal MPI. The arrow points to a nonsignificant finding seen in the apical portion of the anterior wall of the left ventricle. The visual SSS was 1 (SSS < 4). (A) The three axis images show stress and rest MPI images in the short axis (i), vertical axis (ii) and horizontal axis (iii). (B) The bull’s eye image shows the entire myocardium. The red arrow shows the finding seen in the stress MPI, and the white arrow shows the improvement of the finding at rest.
Medicina 57 00774 g001
Medicina 57 00774 g002 550
Figure 2. Abnormal MPI (non-reversible defects: a myocardial scar or severe ischemia). Hypoperfused areas are seen in the apex, inferior, inferior lateral, apical and middle part of the anterior wall (red arrows), and the basal part of the anterior-septal wall (blue arrow) of the left ventricle. (A) The three axis images show stress and rest MPI images in the short axis (i), vertical axis (ii) and horizontal axis (iii). The visual SSS was 33, the SRS was 32, and the SDS was 1, indicating a non-reversible myocardial ischemia. (B) The bull’s eye image shows the entire myocardium. The red arrow shows the hypoperfused areas seen in both the stress and rest MPI (non-reversible defects seen in myocardial infraction, or in severe ischemia); the blue arrow shows the defect in the anterior-septal wall, and the white arrow shows the reversibility in the rest MPI (SDS 1).
Figure 2. Abnormal MPI (non-reversible defects: a myocardial scar or severe ischemia). Hypoperfused areas are seen in the apex, inferior, inferior lateral, apical and middle part of the anterior wall (red arrows), and the basal part of the anterior-septal wall (blue arrow) of the left ventricle. (A) The three axis images show stress and rest MPI images in the short axis (i), vertical axis (ii) and horizontal axis (iii). The visual SSS was 33, the SRS was 32, and the SDS was 1, indicating a non-reversible myocardial ischemia. (B) The bull’s eye image shows the entire myocardium. The red arrow shows the hypoperfused areas seen in both the stress and rest MPI (non-reversible defects seen in myocardial infraction, or in severe ischemia); the blue arrow shows the defect in the anterior-septal wall, and the white arrow shows the reversibility in the rest MPI (SDS 1).
Medicina 57 00774 g002
Medicina 57 00774 g003 550
Figure 3. Box plots of the vitamin D distribution in subjects with and without ischemia. The logistic regression analysis showed that vitamin D (coefficient B = −0.068, p= 0.020, odds ratio = 0.934, confidence interval [0.882, 0.989]), and gender (coefficient B = −1.238, p = 0.003, odds ratio = 0.290, confidence interval [0.128, 0.654]) are independent predictors of ischemia.
Figure 3. Box plots of the vitamin D distribution in subjects with and without ischemia. The logistic regression analysis showed that vitamin D (coefficient B = −0.068, p= 0.020, odds ratio = 0.934, confidence interval [0.882, 0.989]), and gender (coefficient B = −1.238, p = 0.003, odds ratio = 0.290, confidence interval [0.128, 0.654]) are independent predictors of ischemia.
Medicina 57 00774 g003
Table
Table 1. Descriptive statistics and differences of vitamin D levels between subjects with and without ischemia, and between men and women.
Table 1. Descriptive statistics and differences of vitamin D levels between subjects with and without ischemia, and between men and women.
VariableGroupsMedian (Minimum, Maximum)p-Value (Mann-Whitney U-Test)
ischemiaNo18.1 (6.2, 36.6)0.013
Yes14.9 (6.0, 30.1)
genderMale14.9 (6.0, 28.7)0.153
Female17.4 (6.0, 36.6)
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Batsi, C.; Gkika, E.; Astrakas, L.; Papadopoulos, A.; Iakovou, I.; Dogoritis, A.; Fotopoulos, A.; Sioka, C. Vitamin D Deficiency as a Risk Factor for Myocardial Ischemia. Medicina 2021, 57, 774. https://doi.org/10.3390/medicina57080774

AMA Style

Batsi C, Gkika E, Astrakas L, Papadopoulos A, Iakovou I, Dogoritis A, Fotopoulos A, Sioka C. Vitamin D Deficiency as a Risk Factor for Myocardial Ischemia. Medicina. 2021; 57(8):774. https://doi.org/10.3390/medicina57080774

Chicago/Turabian Style

Batsi, Christina, Evangelia Gkika, Loukas Astrakas, Athanassios Papadopoulos, Ioannis Iakovou, Alexandros Dogoritis, Andreas Fotopoulos, and Chrissa Sioka. 2021. "Vitamin D Deficiency as a Risk Factor for Myocardial Ischemia" Medicina 57, no. 8: 774. https://doi.org/10.3390/medicina57080774

Article Metrics

Back to TopTop